Literature DB >> 12860961

Paclitaxel pharmacokinetics, threshold models, and dosing strategies.

Alex Sparreboom, Jaap Verweij.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12860961     DOI： 10.1200/JCO.2003.99.038

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial.

Authors:  Mary Cianfrocca; Sandra Lee; Jamie Von Roenn; Michelle A Rudek; Bruce J Dezube; Susan E Krown; Joseph A Sparano
Journal:  Cancer Chemother Pharmacol       Date:  2011-01-05       Impact factor: 3.333

Review 2.  Effect of age on drug metabolism in women with breast cancer.

Authors:  Jasmeet C Singh; Stuart M Lichtman
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-05       Impact factor: 4.481

3.  Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer.

Authors:  H H Helgason; C M F Kruijtzer; A D R Huitema; S G Marcus; W W ten Bokkel Huinink; M E Schot; J H Schornagel; J H Beijnen; J H M Schellens
Journal:  Br J Cancer       Date:  2006-09-12       Impact factor: 7.640

4.  A Framework for Analyzing the Whole Body Surface Area from a Single View.

Authors:  Marco Piccirilli; Gianfranco Doretto; Donald Adjeroh
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.